Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
How Gene-Editing Therapies Are Revolutionizing ...
By
Rene Pretorius
June 18, 2025
Summary Eli Lilly’s $1.3 billion acquisition of Verve Therapeutics represents a transformative step in addressing
AI Decision Support in Aortic Stenosis Detection
Addressing Physical Inactivity in MENA and Beyond
Healthcare for Older Adults in Türkiye: A Call for Reform
CTO-PCI Technology for Heart Health in Egypt
Mental Healthcare for Youth: Addressing Substance Use and Chronic Conditions
The Impact of Atrial Fibrillation on Quality of Life and Healthcare Costs
The Impact of Immunosenescence on Ageing
Real-World Walking Behaviours and Early-Stage Heart Failure
The Economic Impact of Obesity in Türkiye: A Micro-Costing Analysis
Innovative Funding Models for Non-Communicable Diseases
Cost-effective Treatment: A Closer Look at SGLT2 Inhibitors
Machine Learning to Improve Diagnosis of Long QT Syndrome
1
2
Next »